electroCore to Participate in Upcoming Investor Conferences

Rhea-AI Summary

electroCore (Nasdaq: ECOR) announced that management will participate in two August 2026 investor conferences. The company will attend the Needham 11th Annual Virtual MedTech and Diagnostics Conference on August 11, 2026, hosting virtual one-on-one meetings, and the Canaccord Genuity 46th Annual Growth Conference in Boston on August 11–12, 2026.

Market Reaction – ECOR

-1.89% $5.97

15m delay

-1.89% Vs previous close

$5.97 Last Price

$5.74 $6.13 Day Range

$55.64M Market Cap

0.8x Rel. Volume

Following this news, ECOR has declined 1.89%, reflecting a mild negative market reaction. Our momentum scanner has triggered 2 alerts so far, indicating moderate trading interest and price volatility. The stock is currently trading at $5.97.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ROCKAWAY, N.J., Aug. 03, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the following investor conferences:

• Needham 11th Annual Virtual MedTech and Diagnostics Conference, taking place virtually on Tuesday, August 11, 2026. Management will host one-on-one meetings virtually.
  
• Canaccord Genuity 46th Annual Growth Conference, taking place in Boston, Massachusetts, on Tuesday, August 11, and Wednesday, August 12, 2026, at the InterContinental Boston. Management will present on Tuesday, August 11, at 4:30 p.m. ET and will host one-on-one meetings on Wednesday, August 12.
  

Investors who wish to request a meeting should contact their sales representative at the sponsoring firms or reach out to electroCore Investor Relations at investors@electrocore.com.

About electroCore, Inc.
electroCore, Inc. is a bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company’s two leading prescription products, gammaCore® non-invasive vagus nerve stimulation (nVNS) and Quell® neurostimulator, treat chronic pain syndromes through non-invasive neuromodulation technology. Additionally, the company commercializes its handheld, and personal use Truvaga™ and TAC-STIM™ nVNS products utilizing bioelectronic technologies to promote general wellness and human performance.

For more information, visit www.electrocore.com.

Contact:
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com

FAQ

When will electroCore (ECOR) attend the Needham 11th Annual Virtual MedTech and Diagnostics Conference in 2026?

electroCore will participate in the Needham 11th Annual Virtual MedTech and Diagnostics Conference on Tuesday, August 11, 2026. According to electroCore, the conference will be held virtually and management will host one-on-one investor meetings during the event.

What are the dates and location of electroCore’s participation in the 2026 Canaccord Genuity 46th Annual Growth Conference?

electroCore will participate in the Canaccord Genuity 46th Annual Growth Conference on August 11–12, 2026 in Boston, Massachusetts. According to electroCore, the event will be held at the InterContinental Boston, with both a presentation and one-on-one meetings scheduled.

What time is electroCore’s presentation at the Canaccord Genuity 46th Annual Growth Conference in August 2026?

electroCore is scheduled to present on Tuesday, August 11, 2026, at 4:30 p.m. ET at the Canaccord Genuity conference. According to electroCore, management will also hold one-on-one investor meetings on Wednesday, August 12, 2026.

How can investors request one-on-one meetings with electroCore (ECOR) at the August 2026 investor conferences?

Investors can request meetings through their sales representative at the sponsoring firms or by emailing investors@electrocore.com. According to electroCore, management will host one-on-one meetings at both the Needham virtual conference and the Canaccord Genuity Growth Conference.

Is electroCore’s participation in the Needham MedTech and Canaccord Growth conferences in 2026 virtual or in person?

electroCore’s Needham 11th Annual MedTech and Diagnostics Conference appearance is virtual, while the Canaccord Genuity 46th Annual Growth Conference is in person in Boston. According to electroCore, both events will include opportunities for one-on-one investor meetings.